Strontium
Also known as: Strontium citrate, Strontium ranelate, Strontium salts
A calcium-like element sold for bone support, where supplement salts must not be confused with the restricted medicine strontium ranelate.

Strontium is an element chemically similar to calcium. Supplemental strontium citrate is marketed for bone health, but trials often combine it with other nutrients and cannot isolate its effect. Strontium ranelate is a different prescription medicine restricted in Europe because of cardiovascular and other risks; its efficacy data and dosing cannot be transferred to over-the-counter citrate products.2, 3, 4
- Not an essential nutrient with a U.S. daily value1, 4
- Citrate and ranelate are different interventions1, 4
- Strontium can artificially raise DXA bone-density readings1, 4
- Prescription ranelate has important safety restrictions1, 4
What is Strontium?
Because strontium atoms attenuate X-rays more strongly than calcium, incorporation into bone can increase measured density beyond the change in bone mineral quantity. That complicates interpretation of DXA scans during supplementation.1, 4
Where it comes from
Natural sources
- Rocks, soil, water, and trace amounts in food
- Naturally incorporated into bone at low levels
How it's made
Supplements and medicines use manufactured salts such as citrate or ranelate.
What it does in products
Benefits
Bone density with strontium citrate combinations
limited evidenceEvidence scope and limitations
Oral citrate supplements are distinguished from prescription ranelate and environmental radioactive strontium.
- Supplement trials are commonly multi-ingredient.
- DXA is biased upward when strontium replaces calcium in bone.
- Long-term citrate safety is not well established.
Evidence last checked: 2026-09-28
Side effects & safety
Safety considerations
- Avoid supplemental strontium during pregnancy and breastfeeding unless medically directed.
- Calcium supplements and calcium-rich meals may compete for absorption
- Tetracycline and quinolone antibiotics
- Not for: Cardiovascular or thromboembolic disease without clinician review
- Not for: Kidney disease
- Not for: Using supplement data to interpret DXA without telling the imaging clinician
Amounts studied & product use
These figures describe research or common product use, not a personal dose or treatment recommendation.
In supplement studies and products
No U.S. recommended dietary allowance exists. Combination studies use product-specific citrate doses, while ranelate dosing is not transferable to supplements.
Regulatory status
- Strontium citrate is sold as a dietary supplement but is not FDA-approved to prevent fractures; strontium ranelate is not an FDA-approved osteoporosis drug in the United States.
Bone-density scans can overstate the change
DXA calculates mineral density from X-ray attenuation. Strontium in bone attenuates more strongly than calcium, so part of a rising score can reflect atomic physics rather than an equivalent increase in calcium mineral or proven fracture protection.
4, 2Frequently asked questions
The bottom line
Strontium can change bone measurements, but supplement citrate lacks the fracture evidence and oversight of prescription ranelate—and should not borrow its claims.
References
- Strontium: compound summary. PubChem, National Library of Medicine (2026) · ingredient monograph · CID 5359327
- Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium citrate, vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health-related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures. Aging (2017) · randomized trial · PMID 28130552
- Recommendation to restrict the use of Protelos / Osseor (strontium ranelate). European Medicines Agency (2014) · government guidance
- Toxicological Profile for Strontium. Agency for Toxic Substances and Disease Registry (2004) · government guidance · ATSDR TP-159
- Dietary Supplements. U.S. Food and Drug Administration (2025) · government guidance
Revision history
- Initial publication with claim-level citations, formulation limits, safety context, and editorial evidence review.